<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1186/s13567-025-01475-2</dc:identifier><dc:language>eng</dc:language><dc:creator>Gómez, Álex</dc:creator><dc:creator>Glaria, Idoia</dc:creator><dc:creator>Moncayola, Irati</dc:creator><dc:creator>Echeverría, Irache</dc:creator><dc:creator>Arrizabalaga, Javier</dc:creator><dc:creator>Rodríguez-Largo, Ana</dc:creator><dc:creator>de Blas, Ignacio</dc:creator><dc:creator>Lacasta, Delia</dc:creator><dc:creator>Pérez, Estela</dc:creator><dc:creator>Pérez, Marta</dc:creator><dc:creator>De Diego, Alicia</dc:creator><dc:creator>De-Miguel, Ricardo</dc:creator><dc:creator>Lee, Benhur</dc:creator><dc:creator>Luján, Lluís</dc:creator><dc:creator>Reina, Ramsés</dc:creator><dc:title>Characterization of a recombinant Sendai virus vector encoding the small ruminant lentivirus gag-P25: antiviral properties in vitro and transgene expression in sheep</dc:title><dc:identifier>ART-2025-143426</dc:identifier><dc:description>Abstract
          Small ruminant lentiviruses (SRLV) cause multisystemic chronic inflammatory disease and significant economic losses in sheep and goats worldwide. However, no vaccines or therapies are currently available. In this study, a recombinant Sendai virus (SeV) vector encoding the SRLV gag-P25 gene (rSeV-GFP-P25) from the EV1 strain was generated using In-FUSION cloning and rescued using the SeV reverse genetic system. Transgene expression and stimulation of innate immunity and interferon-stimulated genes (ovine A3Z1, OBST2 and SAMHD1) were evaluated in ovine skin fibroblasts (OSF) transduced with SeV-GFP and rSeV-GFP-P25. Additionally, to characterize the effect of the SRLV restriction in transduced OSF, the SRLV DNA load was quantified at different times post-transduction and post-infection with strain EV1. Using immunohistochemistry and image analysis, transgene expression and tissue distribution of recombinant P25 were studied in two lambs inoculated intranasally, one with rSeV-GFP-P25 and the other with SeV-GFP. rSeV-GFP-P25 induced efficient and transient transgene expression in vitro and in vivo. Furthermore, OSF transduced with rSeV-GFP-P25 presented upregulation of TLR2, TLR3, TLR6, TLR7, RIG-I, MyD88 and IFN-β, whereas SeV-GFP did not induce TLR6 or IFN-β upregulation. Among the interferon-stimulated genes, OBST2 was significantly upregulated after transduction with rSeV-GFP-P25 compared with the empty vector. SRLV restriction gradually increased and persisted after transduction with SeV-GFP and rSeV-GFP-P25, with OSF transduced three times showing cumulative restriction. Forty-eight hours post-inoculation in vivo, marked P25 expression was observed in ciliated epithelial cells and submucosal macrophages/dendritic cells of the nasal mucosa. This study reinforces the important role of the innate immune response in controlling SRLV infection and suggests that rSeV-GFP-P25 is a potential vaccine candidate against SRLV.</dc:description><dc:date>2025</dc:date><dc:source>http://zaguan.unizar.es/record/152192</dc:source><dc:doi>10.1186/s13567-025-01475-2</dc:doi><dc:identifier>http://zaguan.unizar.es/record/152192</dc:identifier><dc:identifier>oai:zaguan.unizar.es:152192</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/MCIU/RTI2018-096172-B-C33</dc:relation><dc:identifier.citation>Veterinary Research 56, 51 (2025), [14 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>